logologo
Search stocks, ETFs, IPOs & more
Quest
arrow
WhatsApp Icon

De Nora India FY26 revenue ₹1,216 cr; Q1 FY27 ahead

DENORA

DE Nora India Ltd

DENORA

Ask AI

Ask AI

Stock in focus ahead of the July-August results season

De Nora India’s upcoming Q1 FY27 result window is drawing attention as investors position for the July-August 2026 reporting season for the quarter ended June 2026. In the data provided, De Nora India was referenced at a current market price (CMP) of ₹858 with a market capitalisation of ₹484 crore. The price-to-earnings (PE) multiple was described as “not meaningful”. Alongside this, a 12-month target range of ₹867 to ₹978 was stated as a Uniresearch estimate. The update timestamp mentioned was 9 July 2026 at 12:47 pm. Investors were also cautioned that quarterly financials for this cycle were not fully available on certain data partners.

Board approval: audited FY26 numbers

A key factual trigger in the note was the board’s approval of audited financial results for FY26. The audited numbers cited were revenue from operations of ₹12,162.31 million and profit for the period of ₹905.54 million. Using a single base unit for comparability, this translates to revenue from operations of ₹1,216.231 crore and profit of ₹90.554 crore (since ₹10 million equals ₹1 crore). These audited FY26 figures provide a broad reference point while the market waits for quarterly disclosures for FY27. No additional line items, margins, or segment details were included in the provided text. Investors will therefore need to rely on exchange filings for full schedules and notes.

Q1 FY27 results: expected timeline and disclosure sources

For Q1 FY27, the result date was described as “July-August 2026 (indicative)”. The note also included a direct Q&A stating the results are expected in the July-August 2026 window in line with the broader NSE and BSE results season. At the same time, it clearly said detailed quarterly estimates are not available for De Nora India at this time. Investors were advised to track Screener.in and NSE/BSE filings directly to confirm the result date and cross-check figures. This is important because the same compilation also contained multiple price and market-cap snapshots that can vary by timestamp and data source. The lack of a consolidated estimate set means market participants are relying more on actual filings than preview numbers.

Trading and valuation snapshots mentioned in the note

Multiple market snapshots were presented. One section highlighted shares trading at ₹858 with market cap at ₹484 crore and PE “not meaningful.” Elsewhere, a separate Q&A stated the current share price as ₹731.75 and market capitalisation as ₹388.45929295 crore, based on its latest share price. Another market line showed “BSE: Today, 11:03 AM” with a price of 721.15, down 7.50, or -1.03%. These differences do not necessarily indicate an error, but they do show that timestamps and sources matter when interpreting market data. Investors typically reconcile such differences by checking the latest exchange quote and the corporate filings page.

Last earnings date and corporate action reference points

The content also listed “Last Earnings Date” as Q4 FY25-26 on 4 May 2026. In the same collection, a line stated “Upcoming Earnings date for De Nora India Ltd. is 4th, May, 2026,” which appears to repeat that date as an earnings marker within the dataset. On corporate actions, the company was stated to have declared a dividend of ₹2.00 on 18 September 2024. The note also referenced past disclosure items such as a “newspaper publication of unaudited financial results” for the quarter ended 30 June 2025, and an item stating that Q1 FY2025 unaudited results were approved on 30 July (as listed). These items provide context on the company’s reporting cadence, but the current focus remains on the Q1 FY27 reporting window.

What the quarterly table shows (Mar 2025 to Mar 2026)

The dataset included a quarterly results table explicitly labelled “All Figures in Cr.” for five quarters ending Mar 2025, Jun 2025, Sep 2025, Dec 2025, and Mar 2026. Net sales were shown moving from ₹20.13 crore (Mar 2025) to ₹41.97 crore (Jun 2025), ₹21.84 crore (Sep 2025), ₹35.84 crore (Dec 2025), and ₹21.97 crore (Mar 2026). Operating profit was positive in four of those quarters, but turned negative at -₹2.27 crore in Mar 2026. Profit after tax (PAT) was ₹3.34 crore (Mar 2025), ₹3.25 crore (Jun 2025), ₹3.87 crore (Sep 2025), ₹2.57 crore (Dec 2025), and -₹0.64 crore (Mar 2026). Adjusted EPS was positive through Dec 2025, but shown at -1.2 in Mar 2026.

Key facts table: FY26 audited numbers and market markers

ItemValue (as stated)Normalized / Notes
FY26 revenue from operations (audited)₹12,162.31 million₹1,216.231 crore
FY26 profit for the period (audited)₹905.54 million₹90.554 crore
CMP (snapshot)₹858As stated in estimates table
Market cap (snapshot)₹484 croreAs stated in estimates table
PENot meaningfulAs stated
Q1 FY27 results dateJuly-August 2026 (indicative)For quarter ending June 2026
12-month target range (Uniresearch estimate)₹867-₹978As stated
Dividend declared₹2.00Dated 18 Sep 2024

Quarterly performance table from the provided dataset

Quarter (All figures in ₹ crore; EPS in ₹)Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Net Sales20.1341.9721.8435.8421.97
Operating Profit3.832.454.022.47-2.27
Profit After Tax3.343.253.872.57-0.64
Adjusted EPS6.296.127.294.84-1.2

Market impact: what investors are watching now

Based on the information provided, the near-term market focus is less about a published quarterly estimate and more about confirmation of the Q1 FY27 result date and the eventual filing details. The note itself highlighted that detailed quarterly estimates were not available and urged investors to cross-check numbers with exchange filings. The stated target range of ₹867-₹978 sits close to the cited CMP of ₹858 in the same note, suggesting a “tracking stance” as explicitly described. With PE labelled “not meaningful,” investors typically lean on operating trends, audited annual numbers, and quarter-on-quarter changes in sales and profitability rather than headline valuation multiples alone. The quarterly table also shows that profitability can vary meaningfully across quarters, including a negative operating profit and negative PAT in Mar 2026. That variability increases the importance of verified disclosures for the June 2026 quarter.

Why the FY26 audit and Q1 FY27 timing matter

The audited FY26 approval gives investors a confirmed annual anchor number for revenue from operations and profit for the period, both stated explicitly. The next key datapoint is when Q1 FY27 results are released and whether quarterly operating and net profit trends remain volatile or stabilise. The content also demonstrates that data availability may lag on some platforms, which is why tracking NSE/BSE filings is repeatedly advised. While some parts of the dataset provide separate price and market-cap snapshots, the most reliable confirmation for results dates and financial statements will come through exchange disclosures. For investors following the stock into the results season, the practical task is to reconcile market snapshots with official documents and ensure comparisons are made using consistent units.

Conclusion

De Nora India’s board-approved audited FY26 results reported revenue from operations of ₹1,216.231 crore and profit for the period of ₹90.554 crore. The next immediate catalyst flagged is the Q1 FY27 result announcement, expected in the July-August 2026 window. The note also highlights that quarterly estimates are not available at this time and encourages investors to rely on Screener.in and NSE/BSE filings to verify the result date and reported numbers. Any further clarity on quarterly trends will depend on those filings when released.

Frequently Asked Questions

The board approved FY26 audited results showing revenue from operations of ₹12,162.31 million (₹1,216.231 crore) and profit for the period of ₹905.54 million (₹90.554 crore).
They are expected in the July-August 2026 window, as stated in the provided note for the quarter ending June 2026.
The estimates table cited a CMP of ₹858 and market capitalisation of ₹484 crore, with PE described as not meaningful.
A 12-month Uniresearch estimate target range of ₹867 to ₹978 was stated.
The note advises checking Screener.in and the company’s NSE/BSE filings directly, and cross-checking figures before making decisions.

Did your stocks survive the war?

See what broke. See what stood.

Live Q1 Earnings Tracker